AFT Pharmaceuticals Limited (NZE:AFT)

AFT Pharmaceuticals Financials Overview

Financials in millions NZD. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	254.71	254.71	208.02	195.41	156.64	130.31
Revenue Growth	7.81%	22.44%	6.45%	24.75%	20.20%	15.21%
Gross Profit Gross Profit Growth	110.55	110.55	91.71	88.27	72.98	61.78
Operating Income Operating Income Growth	24.45	24.45	17.65	24.24	19.67	20.39
Net Income Net Income Growth	14.73	14.73	11.96	15.61	10.65	19.85
Earnings Per Share EPS Growth	0.14	0.14	0.11	0.15	0.10	0.19
EPS Growth	-13.48%	27.27%	-26.10%	46.48%	-46.41%	168.07%

Revenue by Geography

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Australia Australia Growth	150.83	150.83	127.1	108.21	94.12	76.67
New Zealand New Zealand Growth	59.71	59.71	53.79	48.72	44.03	35.07
Asia Asia Growth	15.65	15.65	11.09	10.69	6.81	5.49
International International Growth	28.53	28.53	16.04	27.79	11.68	13.09
Total Total Growth	254.71	254.71	208.02	195.41	156.64	130.31

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	10.24	10.24	11.11	12.04	4.75	7.94
Total Debt Total Debt Growth	54.11	54.11	30	32.19	38.05	40.51
Net Cash (Debt) Net Cash Growth	-43.87	-43.87	-18.89	-20.15	-33.3	-32.57
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-0.42	-0.42	-0.18	-0.19	-0.32	-0.31

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	-9.54	-9.54	13.18	28.86	11.63	14.15
Capital Expenditures CapEx Growth	-0.12	-0.12	-0.28	-0.12	-0.2	-0.33
Free Cash Flow Free Cash Flow Growth	-9.66	-9.66	12.9	28.75	11.43	13.82
Free Cash Flow Growth	-	-	-55.14%	151.44%	-17.30%	2003.96%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	43.40%	43.40%	44.09%	45.17%	46.59%	47.41%
Operating Margin	9.60%	9.60%	8.48%	12.40%	12.56%	15.65%
Pretax Margin	8.59%	8.59%	7.71%	11.27%	10.09%	14.34%
Profit Margin	5.78%	5.78%	5.75%	7.99%	6.80%	15.23%
FCF Margin	-3.79%	-3.79%	6.20%	14.71%	7.30%	10.61%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Aug 1, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Dividend Per Share Dividend Per Share Growth	0.025	0.025	0.018	0.016	0.011
Dividend Per Share Growth	63.39%	38.89%	12.50%	45.45%	-
Dividend Yield	0.52%	0.75%	0.68%	0.52%	0.33%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 1, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	34.36	23.92	23.58	21.03	34.06	19.04
Forward PE	25.61	18.37	16.79	19.41	19.12	18.43
P/FCF Ratio	-	-	21.88	11.42	31.74	27.34
PS Ratio	1.98	1.38	1.36	1.68	2.32	2.90

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 31, 2026

Data Sources Report a data error